Latest Commercialization News

Cardiex Limited reported a $2.06 million cash outflow for Q3 2025 but is driving cost savings and new revenue streams while planning a capital raise to reach positive cash flow.

BluGlass Limited has achieved a world-record 1250mW single-mode GaN laser chip and strengthened its commercial pipeline with a $120,000 repeat order, positioning itself for rapid growth in photonics markets.

Conrad Asia Energy has secured a pivotal Gas Sales Agreement with Indonesia’s state utility PLN, linking Mako gas prices to the Indonesian Crude Price and advancing its farmout strategy while increasing its stake in the Duyung PSC to 91.5%.

AVADA Group Limited reported a seasonally subdued quarter ending March 2025 but achieved positive operating cash flow through disciplined cost reductions and operational efficiencies. A strategic review of its New Zealand operations is underway amid challenging market conditions.

Lithium Universe Limited has delivered a robust Definitive Feasibility Study for its Bécancour Lithium Carbonate Refinery, confirming strong economic viability and progressing toward project funding and strategic collaborations.

BMG Resources advances its gold exploration with ongoing drilling at Abercromby, promising near-surface high-grade results at Bullabulling, and strategic positioning near producing mines at Invincible.

White Energy Company Limited has marked significant progress in its mining exploration and coal technology divisions during the March 2025 quarter, including achieving a key farm-in milestone and raising $3.7 million net from an entitlement offer.

Omega Oil and Gas has reported robust oil and gas flows from its Canyon-1H well in Queensland’s Bowen Basin, confirming commercial potential and securing $7 million in fresh capital alongside a strategic board appointment.

Energy World Corporation has appointed a global investment bank to spearhead funding efforts for its LNG and power projects in the Philippines, while reporting a $3.62 million operating cash outflow and the resignation of a senior executive.

Anatara Lifesciences reports mixed results from its Phase II GaRP-IBS trial, missing the primary efficacy target but showing significant improvements in anxiety and patient-reported relief, while advancing its anti-obesity pre-clinical program.

Lindian Resources has made significant strides in advancing its Kangankunde Rare Earths Project, securing key construction contracts, initiating site works ahead of schedule, and strengthening its leadership team. The company is also progressing downstream testwork with ANSTO and actively pursuing funding opportunities to underpin development.

Eden Innovations reports robust growth in EdenCrete®Pz7 sales, driven by expanded orders from Holcim Ecuador and the USA, alongside strategic US property sales aimed at debt reduction and operational efficiency.